Welcome to the e-CCO Library!

DOP089: Individualised variations in the gut microbiota during remission precede Crohn’s disease flares
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Braun1, A. Di Segni1, S. Neuman1, N. Levhar1, M. Bubis1, O. Picard1, M. BenShoshan1, G. Efroni1, S. Farage Barhom1, E. Glick Saar1, A. Lahad1, D. Shouval1, B. Weiss1, A. Lahat1, R. Eliakim1, S. Ben-Horin1, U. Kopylov1, The Leona M. and Harry B. Helmsley Charitable Trust supported Israeli IBD Research Nucleus (IIRN), Y. Haberman1,2*

Created: Thursday, 21 February 2019, 9:14 AM
DOP089: Microbiota profiles in treatment-naïve Norwegian IBD and non-IBD patients: part of the European Union IBD character consortium
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Ricanek*1, S. Vatn1, T. Lindahl2, E. Ciemniejewska2, J. Jahnsen1, C. Casen2, M. H. Vatn1

Created: Friday, 22 February 2019, 9:49 AM
DOP089: PTPN2 controls intestinal inflammation and promotes colitis-associated tumour formation via control of inflammasome activation and IL-1alpha release
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spalinger M.*1, Hering L.1, Manzini R.1, Riggs J.B.1, Gottier C.1, Atrott K.1, Fettelschoss A.2, Kündig T.2, Fried M.1,3, Rogler G.1,3, Scharl M.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
DOP08: Cellular and molecular interaction of MAIT in mucosal tissue and their role in inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bosáková, V.(1,2)*;Frič, J.(1,3);
Created: Friday, 14 July 2023, 10:43 AM
DOP08: Serum proteomics predict endoscopic remission in patients with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Alsoud, D.(1);Sudhakar, P.(1);Sabino, J.(1,2);Ferrante , M.(1,2);Verstockt , B.(1,2);Vermeire, S.(1,2)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP08: The regulatory landscape of intestinal cells—investigating the transcriptional effect of autophagy impairment observed in Crohn’s disease using organoid and network biology approaches
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Treveil*1,2, P. Sudhakar1,3, Z. Matthews4, T. Wrzesinkski1, E. Jones1,2, P. Powell4, T. Wileman2,4, I. Hautefort1, L. Hall2, F. Di Palma1, W. Haerty1, T. Korcsmaros1,2

Created: Friday, 22 February 2019, 9:41 AM
DOP08: Transcriptional signatures of blood derived immune cells associated with disease location-based heterogeneity in IBD
Year: 2022
Source: ECCO'22
Authors: Sudhakar, P.(1);Verstockt, B.(1,2);Cremer, J.(3);Verstockt, S.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Costes1, I. Tindemans1, M.E. Joosse1, M.A. Aardoom2, M.M.E. Jongsma2, R.H.C. Raatgeep1, D.H. van Haaften1, K.L. Alexander3, L.W. Duck3, A.P. Heikema4, P. Kemos5, J.C. Escher2, F.M. Ruemmele6, N.M. Croft7, C.O. Elson8, L. de Ridder2, J.N. Samsom1

Created: Thursday, 30 January 2020, 10:12 AM
DOP090: Risk factors for bacteraemia in hospitalised patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Goren1,2*, A. Israel3, A. Brom4, G. Segal4

Created: Thursday, 21 February 2019, 9:14 AM
DOP090: The α7 nicotinic acetylcholine receptor agonist GTS-21 attenuate DSS-induced colitis by improving intestinal mucosal barrier function
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zhang H.*1, Zhu Y.2

Created: Wednesday, 20 February 2019, 10:36 AM
DOP090: The role of the microbiome in clinical response to golimumab in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Monast*, S. Telesco, K. Li, K. Hayden, C. Brodmerkel

Created: Friday, 22 February 2019, 9:49 AM
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jacobs, I.(1)*;Deleu, S.(2);Cremer, J.(1,2);De Hertogh, G.(3);Vermeire, S.(2,4);Breynaert, C.(1,5);Vanuytsel, T.(2,4);Verstockt, B.(2,4);
Created: Friday, 14 July 2023, 10:43 AM
DOP09: Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Moniruzzaman*1,2, R. Wang2, K. Wong2, H. Tong2, M. McGuckin3, S. Hasnain1,2

Created: Friday, 22 February 2019, 9:41 AM
DOP09: Mirikizumab-induced transcriptome changes in patient biopsies at Week 12 are maintained through Week 52 in patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Johnson, T.(1);Steere, B.(2);Zhang, P.(1);Zang, Y.(1);Higgs, R.(2);Gottlieb, K.(2);Reinisch, W.(3);Panés, J.(4);Krishnan, G.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP09: Phenotypic and genetic determinants of medication response in patients in the UK IBD BioResource
Year: 2022
Source: ECCO'22
Authors: Zhang, Q.(1);Fachal, L.(1);Shawky, R.(2);Lamb, C.(3,4);Parkes, M.(2,5,6);Anderson, C.(1);Raine, T.(1,6);
Created: Friday, 11 February 2022, 3:52 PM
DOP10 Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Kucharzik1, R. Wilkens2,3, G. Maconi4, M.A. D’Agostino5, M. Le Bars6, M. Nazar7, S. Sloan8, M. Lahaye9, L. Ni10, E. Ercole11, M. Alloca12, N. Machková13, C. Maaser14

Created: Thursday, 30 January 2020, 10:12 AM
DOP10: Early intestinal resection in Crohn's Disease is not associated with severe long-term disease course
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Grellier, N.(1,2)*;Kirchgesner, J.(1);Uzzan, M.(3,4);Mclellan, P.(1);Stefanescu, C.(3,5);Lefèvre, J.H.(6);Panis, Y.(5,7);Sokol, H.(1);Beaugerie, L.(1);Treton, X.(3,5);Seksik, P.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP10: Intestinal Ultrasound at IBD diagnosis predicts major disease events – A Copenhagen IBD cohort study
Year: 2022
Source: ECCO'22
Authors: Madsen, G.R.(1);Attauabi, M.(2);Wilkens, R.(1);Ilvemark, J.F.K.F.(2);Theede, K.(1);Bjerrum, J.T.(2);Dorn-Rasmussen, M.(3);Jansson, S.(3);Wewer, A.V.(3);Bendtsen, F.(1);Seidelin, J.B.(2);Boysen, T.(1);Burisch, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP10: Persistent sonographic Inflammation as a predictor of clinical complications in patients with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Vaughan, R.(1);Tjandra, D.(1);Patwardhan, A.(1);Mingos, N.(1);Gibson, R.(2);Boussioutas, A.(1);Christensen, B.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP10: Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Shubhakar*1, B. Jansen1, A. Adams2, K. Reiding3, N. Ventham4, D. Bergemalm5, P. Urbanowicz1, R. Gardner1, IBD-BIOM Consortium1, J. Halfvarson6, J. Satsangi2, D. Fernandes1, M. Wuhrer7, D. Spencer1

Created: Friday, 22 February 2019, 9:41 AM